Weekly Digest – 01-07 Apr 2023 Weekly Digest – 01-07 Apr 2023 05 Apr 2023: Lynparza (Olaparib) / Imfinzi (Durvalumab) / Ovarian Cancer / AstraZeneca: Phase 3 DUO-O trial met the primary endpoint of progression-free survival AstraZeneca reported encouraging topline […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id